Currently out of the existing stock ratings of Ravi Misra, 2 are a BUY (40%), 2 are a HOLD (40%), 1 are a SELL (20%).

Ravi Misra

Work Performance Price Targets & Ratings Chart

Analyst Ravi Misra, currently employed carries an average stock price target met ratio of 76.67% that have a potential upside of 16.45% achieved within 98 days. Previously, Ravi Misra worked at BERENBERG.

Ravi Misra’s has documented 21 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TDOC, Teladoc at 01-Nov-2022.

Wall Street Analyst Ravi Misra

Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 11/1/2022. The price target of $33 was fulfilled within 10 days with a profit of $4.12 (14.27%) receiving and performance score of 14.27.

Average potential price target upside

ALGN Align Technology TDOC Teladoc INSP Inspire Medical Systems

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$275

$66.42 (31.84%)

$285

12 days ago
(24-Oct-2024)

27/38 (71.05%)

$58.58 (27.07%)

149

Buy

$250

$41.42 (19.86%)

$270

12 days ago
(24-Oct-2024)

5/11 (45.45%)

$33.58 (15.52%)

273

Buy

$275

$66.42 (31.84%)

$285

12 days ago
(24-Oct-2024)

14/33 (42.42%)

$58.58 (27.07%)

93

Buy

$276

$67.42 (32.32%)

$325

12 days ago
(24-Oct-2024)

21/29 (72.41%)

$59.58 (27.53%)

97

Hold

$320

$111.42 (53.42%)

$260

6 months 21 days ago
(15-Apr-2024)

8/14 (57.14%)

$15.26 (5.01%)

142

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ravi Misra?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?